Christian O Henry
CIK 1263805 · See Remarks · last filed 2026-10-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ILMN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
MENLO PARK, CA 94025
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WVE | Director | 23,400 | $3.37 | $78.7K | -$1.56M | 13 | 2026-10-07 |
| DNA | Director | 19,310 | $10.53 | $203.3K | -$255.2K | 4 | 2026-09-16 |
| PACB | See Remarks | 3,581,813 | $2.38 | $8.53M | -$9.45M | 27 | 2026-03-04 |
| Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Director | 1,339,641 | $0.01 | $8.4K | -$20.53M | 20 | 2024-06-14 |
| ILMN | EVP & Chief Commercial Officer | 17,531 | $277.66 | $4.87M | -$67.35M | 115 | 2017-01-31 |
Recent Filings · Page 7 of 21
204 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-04-05 | Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Sell (S) | −4,499 | -$5.9K | EDGAR |
| 2023-03-16 | Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Sell (S) | −4,499 | -$6.2K | EDGAR |
| 2023-03-06 | PACB | Mixed | +580,918 | -$130.7K | EDGAR |
| 2023-02-22 | PACB | Sell (S) | −1,530 | -$15.7K | EDGAR |
| 2023-02-03 | Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Sell (S) | −4,499 | -$9.4K | EDGAR |
| 2023-01-06 | Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Sell (S) | −4,499 | -$7.1K | EDGAR |
| 2022-12-05 | Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Sell (S) | −4,499 | -$8.3K | EDGAR |
| 2022-12-02 | PACB | Sell (S) | −45,000 | -$488.0K | EDGAR |
| 2022-11-07 | Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Sell (S) | −49,490 | -$126.7K | EDGAR |
| 2022-09-19 | PACB | Sell (S) | −91,307 | -$527.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.